Flagship Ventures Fund IV General Partner LLC Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Flagship Ventures Fund IV General Partner LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Flagship Ventures Fund IV General Partner LLC for May 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.18 | 10,746 | 754,113 | 6,420,766 | 6.4 M to 6.4 M (-0.17 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 69.45 | 69,254 | 4,809,448 | 6,431,512 | 6.5 M to 6.4 M (-1.07 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.18 | 56,406 | 3,958,353 | 21,986,399 | 22 M to 22 M (-0.26 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 69.45 | 363,594 | 25,250,331 | 22,042,805 | 22.4 M to 22 M (-1.62 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 72.44 | 367 | 26,584 | 6,500,766 | 6.5 M to 6.5 M (-0.01 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 2,551 | 182,433 | 6,501,133 | 6.5 M to 6.5 M (-0.04 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 3,900 | 274,780 | 6,503,684 | 6.5 M to 6.5 M (-0.06 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 7,443 | 512,185 | 6,507,584 | 6.5 M to 6.5 M (-0.11 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 23,199 | 1,557,822 | 6,515,027 | 6.5 M to 6.5 M (-0.35 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 42,540 | 2,797,690 | 6,538,226 | 6.6 M to 6.5 M (-0.65 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 72.44 | 1,933 | 140,017 | 22,406,399 | 22.4 M to 22.4 M (-0.01 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 13,408 | 958,861 | 22,408,332 | 22.4 M to 22.4 M (-0.06 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 20,492 | 1,443,793 | 22,421,740 | 22.4 M to 22.4 M (-0.09 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 39,082 | 2,689,404 | 22,442,232 | 22.5 M to 22.4 M (-0.17 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 121,771 | 8,176,971 | 22,481,314 | 22.6 M to 22.5 M (-0.54 %) |
| May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 223,314 | 14,686,491 | 22,603,085 | 22.8 M to 22.6 M (-0.98 %) |
| May 20 2020 | AXLA | Axcella Health Inc ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 4.75 | 1,900,000 | 9,025,000 | 2,886,023 | 986 K to 2.9 M (+192.69 %) |
| May 20 2020 | AXLA | Axcella Health Inc ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 4.75 | 380,000 | 1,805,000 | 1,056,752 | 676.8 K to 1.1 M (+56.15 %) |
| May 20 2020 | AXLA | Axcella Health Inc ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 4.75 | 1,520,000 | 7,220,000 | 4,808,780 | 3.3 M to 4.8 M (+46.22 %) |
| May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 2,281,179 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
| May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,610,000 | 0 | 6,580,766 | 8.2 M to 6.6 M (-19.66 %) |
| May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 8,390,000 | 0 | 22,826,399 | 31.2 M to 22.8 M (-26.88 %) |